This study is to investigate the safety of NS-9 and to see how well it is tolerated in
patients with cancer that has metastasized (spread) to the liver from another primary tumor.
NS-9 is a drug developed to go to the liver to cause cell death specifically in tumor cells.
This study is also set up to determine the best dose to use.